Advertisement
The Investor Day will be held at the offices of inVentiv's Chandler ChiccoAgency (CCA) business unit, located at 450 West 15th Street, Suite #700 in NewYork City. Please go tohttp://selectsurvey.inventivcommunications.com/TakeSurvey.aspx?SurveyID=88KI956 to request an invitation. Those who do not have Internet access can call(732) 537-4804.
Advertisement
The meeting is open to analysts and investors and will be accessible bylive audio webcast on inVentiv Health's website athttp://www.inventivhealth.com/health/newsroom/webcasts.asp. Presentationslides also will be available for all participants and an archived version ofthe webcast will be available on inVentiv Health's website for one weekfollowing the presentation.
To listen to the presentation live, please dial 800-358-8448 (Domestic) or706-634-1367 (International). A replay of the call will be availableimmediately following the call through December 18, 2007 at 800-642-1687(Domestic) or 706-645-9291 (International). The conference ID number for thereplay is 23949575.
About inVentiv Health
inVentiv Health, Inc. (Nasdaq: VTIV) is an insights-driven globalhealthcare leader that provides dynamic solutions to deliver customer andpatient success. inVentiv delivers its customized clinical, sales, marketingand communications solutions through its four core business segments: inVentivClinical, inVentiv Communications, inVentiv Commercial, and inVentiv PatientOutcomes. inVentiv Health's client roster is comprised of more than 275leading pharmaceutical, biotech, life sciences and healthcare payor companies,including all top 20 global pharmaceutical manufacturers. For moreinformation, visit http://www.inventivhealth.com.
This press release contains forward-looking statements within the meaningof the Private Securities Litigation Reform Act of 1995. Such forward-lookingstatements involve known and unknown risks that may cause inVentiv Health'sperformance to differ materially. Such risks include, without limitation:changes in trends in the pharmaceutical industry or in pharmaceuticaloutsourcing; our ability to compete successfully with other services in themarket; our ability to maintain large client contracts or to enter into newcontracts; uncertainties related to future incentive payments; and, ourability to operate successfully in new lines of business. Readers of thispress release are referred to documents filed from time to time by inVentivHealth Inc. with the Securities and Exchange Commission for further discussionof these and other factors.
SOURCE inVentiv Health, Inc.
